PureTech Health (PRTC) Debt Ratio (2020 - 2023)

PureTech Health (PRTC) reported Debt Ratio of 0.02 for Q4 2023, up 203.32% year-over-year from 0.01 in Q4 2022, and up 203.32% quarter-over-quarter from 0.01 in Q4 2022.

PureTech Health (PRTC) Debt Ratio (2020 - 2023) Analysis & Trends

PureTech Health (PRTC) has 4 years of Debt Ratio data on file, last reported at 0.02 in Q4 2023.

  • Debt Ratio for Q4 2023 came in at 0.02, up 203.32% year-over-year; the trailing twelve-month figure through Dec 2023 was 0.02 (up 203.32% YoY), and the FY2023 annual result was 0.02, up 203.32% from the prior year.
  • Debt Ratio improved to 0.02 in Q4 2023 per PRTC's latest filing, from 0.01 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.02 in Q4 2023 and troughed at 0.01 in Q4 2022.
  • A 4-year average of 0.02 and a median of 0.02 in 2020 frame the typical range for Debt Ratio.
  • The sharpest annual moves came in 2022 and 2023: Debt Ratio sank 54.08% in 2022, then jumped 203.32% in 2023.
  • A 4-year view of Debt Ratio shows it stood at 0.01 in 2020, then grew by 6.77% to 0.02 in 2021, then slumped by 54.08% to 0.01 in 2022, then jumped by 203.32% to 0.02 in 2023.
  • Business Quant data shows PRTC's Debt Ratio at 0.02 in Q4 2023, 0.01 in Q4 2022, and 0.02 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.18
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 PureTech Health 86.36 Mn -190.94 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 0.02
Dec 31, 2022 0.01
Dec 31, 2021 0.02
Dec 31, 2020 0.01